Efficacy of Escitalopram in the Treatment of Internet Addiction
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study was to determine whether Lexapro (Escitalopram) is safe and effective in treating problematic internet use.
Condition or disease
Many individuals experience marked distress and functional impairments as a result of their perceived inability to control their 'non-essential' (non-job/school related) use of the Internet. Frequently these people develop a preoccupation with the Internet, a need for escape to the Internet, and increasing irritability when trying to cut back use of the Internet. There have been no studies to date looking at the effectiveness of medications in the treatment of this disorder. In our clinical experience, we find these patients with Internet addiction usually respond to serotonin reuptake inhibitors within 12 weeks. This study will examine the efficacy of escitalopram in Internet addiction among adults.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subject has signed an informed consent form
Current diagnosis of Internet addiction
Age ³ 18
Subject must be able to take oral medication
Subject may be in psychotherapy initiated at least three months prior to Screening. Subject must not discontinue or otherwise alter this therapy during the study.
In the opinion of the investigator, the subject is capable of complying with all study procedures.
Current suicidal or homicidal ideation
Subject has a primary diagnosis of schizophrenia or other psychotic disorders
Subject has a primary diagnosis of Bipolar I disorder
Current DSM-IV diagnosis of substance dependence or abuse, excluding nicotine
Women of child-bearing potential who are pregnant, nursing, or not using contraception
Use of antidepressants at a therapeutic level for the treatment of problematic internet use within 2 weeks prior to study entry (or 4 weeks for use of MAOIs, or 6 weeks for use of fluoxetine)
Current use of antidepressants at a therapeutic level for the treatment of a disorder other than problematic internet use